Skip to content

Hidden Link Between Meatal Stenosis and Primary Nocturnal Enuresis in Children

Investigating the Hidden Link Between Meatal Stenosis and Primary Nocturnal Enuresis in Children

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07424651
Enrollment
400
Registered
2026-02-20
Start date
2021-01-31
Completion date
2025-03-10
Last updated
2026-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children, Meatal Stenosis, Primary Nocturnal Enuresis

Brief summary

This study aimed to investigate the association between meatal stenosis and primary nocturnal enuresis severity, and evaluated therapeutic outcomes following surgical correction.

Detailed description

Primary nocturnal enuresis (PNE) is a prevalent pediatric condition characterized by involuntary urination during sleep in children aged five years or older who have never achieved consistent nighttime dryness. The prevalence of PNE decreases with age, affecting approximately 15% of five-year-old and decreasing to 1-2% by adolescence. Meatal stenosis, defined as the pathological narrowing of the urethral meatus, is an underexplored potential factor. This condition is known to cause obstructed urinary flow, incomplete bladder emptying, and increased bladder pressure, all of which may contribute to enuresis. The incidence of meatal stenosis is higher in circumcised males but can also occur in uncircumcised males and females due to inflammation, trauma, or infection

Interventions

PROCEDUREMeatoplasty Primary nocturnal enuresis.

Patients diagnosed with primary nocturnal enuresis.

Sponsors

New Valley University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
7 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Male children aged 7-12 years. * Diagnosed with primary nocturnal enuresis. * Evaluated and treated at the study center between January 2021 and December 2024. * Confirmed diagnosis of meatal stenosis based on clinical examination and uroflowmetry when indicated. * Patients who underwent meatoplasty and completed the prescribed follow-up period.

Exclusion criteria

* Secondary enuresis (previously dry for ≥ 6 months before recurrence of bedwetting). * Known neurological disorders (e.g., spina bifida, cerebral palsy) or developmental delays. * Structural anomalies of the urinary tract other than meatal stenosis (e.g., posterior urethral valves, vesicoureteral reflux). * Children who did not complete the follow-up or had incomplete clinical records.

Design outcomes

Primary

MeasureTime frameDescription
Association between Meatal Stenosis and primary nocturnal enuresis3 years from collecting the data from the databaseAssociation between Meatal Stenosis and primary nocturnal enuresis was assessed to determine whether there is a significant relationship between the presence of meatal stenosis and the occurrence of primary nocturnal enuresis in male children aged 7-12 years.

Secondary

MeasureTime frameDescription
Resolution of primary nocturnal enuresis post-meatoplasty3 years from collecting the data from the databaseResolution of primary nocturnal enuresis post-meatoplasty was assessed to assess the effectiveness of meatoplasty in resolving primary nocturnal enuresis in children with meatal stenosis.
Need for Revision Meatoplasty3 years from collecting the data from the databaseNeed for Revision Meatoplasty was assessed in patients due to persistent or recurrent meatal stenosis after the initial surgery.
Prevalence of Meatal Stenosis in primary nocturnal enuresis patients3 years from collecting the data from the databasePrevalence of Meatal Stenosis in primary nocturnal enuresis patients was assessed among children diagnosed with primary nocturnal enuresis within the study period (2021-2024).
Incidence of complications3 years from collecting the data from the databaseAny complications or adverse events following meatoplasty, including infection, scarring, or urinary retention were recorded.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026